05 September 2024
The Russian Direct Investment Fund (RDIF) and the Mongolian pharmaceutical company MEIC have agreed to cooperate in this area. The partnership includes collaborative investments in initiatives to transfer technology and localize the production of Russian pharmaceuticals in Mongolia.
RDIF CEO Kirill Dmitriev highlighted that localization not only brings additional advantages, but also boosts scientific and personnel competencies, advances technologies, and implements the best industry practices.
RDIF and MEIC have also committed to collaborating to attract co-investors and global partners to support projects in Mongolia focused on the transfer and localization of drug production technologies.
Print06 September 2024
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
The Russian government will support the development and production of modern drugs
16 September 2024
Russia’s Long-Lasting Flu Vaccine Undergoes Trials
16 September 2024
Moscow to Launch Digitalization Course for Students
12 September 2024
Russia has created an oral drug aimed at treating obesity and diabetes
12 September 2024